The BioBusiness Asia (BBA) conference, one of the Bio Taiwan 2015 highlights, opened in Taipei Wednesday, attended by business, government and academic representatives in the bio technology sector from countries in the Asia-Pacific region.
Older women with mild memory impairment worsened about twice as fast as men, U.S. researchers reported Tuesday, part of an effort to unravel why women are especially hard-hit by Alzheimer's.
As drugs go, it's dirt cheap, potent and deadly. And it creates surreal, pitiful scenes like this: a man running down the street buck naked, fleeing from imaginary dogs.
A 15-minute, on-the-spot blood test for Ebola was as accurate in a patient trial as the most widely used laboratory-based test, its U.S.-based developers said Friday.
Millions of people will be able to see a doctor on their smartphones or laptops for everyday ailments once the nation's largest drugstore chain and two major insurers expand a budding push into virtual health care.
Federal health advisers on Tuesday recommended approval for a highly anticipated cholesterol drug from Sanofi and Regeneron Pharmaceuticals, but with the caveat that more data is needed about its long-term ability to reduce heart attacks.
The drug industry's decade-spanning search for a female equivalent to Viagra took a major step forward Thursday, as U.S. government experts recommended approval for a pill to boost sexual desire in women.
A local professor on Friday unveiled a needle coated with a thin film of metallic glass that he said would ease the pain of being pricked with a needle in various medical applications in the future.
The Chulu Ranch (初鹿牧場) claimed yesterday never to have used pesticides in its dried hibiscus leaf products since 2006, and expressed its bafflement at the Taipei City's Department of Health (DOH, 台北市衛生局) .....
Patients with chronic heart failure, a disabling, deadly disease that worsens as the heart gradually pumps less efficiently, are getting a much-needed new option with U.S. approval Wednesday of a novel drug from Amgen Inc.